Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02955290Phase 1/2Active Not Recruiting
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
Advanced Head and Neck Squamous Cell CarcinomaAdvanced Squamous Non-Small Cell Lung CarcinomaLung Non-Small Cell Carcinoma+13 more
PrincipalinvestigatorStart date: 2016-12-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Arya Amini

City of Hope Medical Center

Related
7 trials

Shared therapeutic areas:

Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8+6 more
Similarity Score17%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+6 more
Similarity Score17%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Metastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+6 more
Similarity Score17%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more
Similarity Score15%

Kathrin Milbury

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+5 more
Similarity Score15%

Anurag K Singh

Roswell Park Cancer Institute

Related
8 trials

Shared therapeutic areas:

Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more

Worked with same sponsors:

Roswell Park Cancer Institute
Similarity Score15%

David S Hong

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more
Similarity Score15%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+4 more
Similarity Score13%

Siqing Fu, MD, PhD

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+4 more
Similarity Score13%

Jing Zeng

Fred Hutch/University of Washington Cancer Consortium

Related
5 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+4 more
Similarity Score13%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02955290Phase 1/2PrincipalInvestigator

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Advanced Head and Neck Squamous Cell CarcinomaAdvanced Squamous Non-Small Cell Lung CarcinomaLung Non-Small Cell Carcinoma+13 more
Active Not Recruiting

All 1 trials loaded